| Product Code: ETC9547607 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Acute Myeloid Leukemia Diagnostics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Acute Myeloid Leukemia Diagnostics Market - Industry Life Cycle |
3.4 Sweden Acute Myeloid Leukemia Diagnostics Market - Porter's Five Forces |
3.5 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.10 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Acute Myeloid Leukemia Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of acute myeloid leukemia (AML) cases in Sweden |
4.2.2 Technological advancements in diagnostic tools and techniques for AML |
4.2.3 Growing investments in healthcare infrastructure and research in Sweden |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic testing in Sweden |
4.3.2 Limited availability of skilled healthcare professionals specialized in AML diagnostics |
4.3.3 High costs associated with advanced diagnostic technologies for AML |
5 Sweden Acute Myeloid Leukemia Diagnostics Market Trends |
6 Sweden Acute Myeloid Leukemia Diagnostics Market, By Types |
6.1 Sweden Acute Myeloid Leukemia Diagnostics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Consumables & Accessories, 2021- 2031F |
6.2 Sweden Acute Myeloid Leukemia Diagnostics Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.2.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.2.4 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Bone Marrow Test, 2021- 2031F |
6.2.5 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.2.6 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Immunophenotyping, 2021- 2031F |
6.2.7 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.3 Sweden Acute Myeloid Leukemia Diagnostics Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Myeloblastic(M0), 2021- 2031F |
6.3.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Myeloblastic(M1), 2021- 2031F |
6.3.4 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Myeloblastic (M2), 2021- 2031F |
6.3.5 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Promyelocytic(M3), 2021- 2031F |
6.3.6 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Myelomonocytic(M4), 2021- 2031F |
6.3.7 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Monocytic(M5), 2021- 2031F |
6.3.8 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Megakaryocytic(M7), 2021- 2031F |
6.3.9 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Megakaryocytic(M7), 2021- 2031F |
6.4 Sweden Acute Myeloid Leukemia Diagnostics Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By 65 and Above, 2021- 2031F |
6.4.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Below 21, 2021- 2031F |
6.4.4 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By 21-29, 2021- 2031F |
6.4.5 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By 30-65, 2021- 2031F |
6.5 Sweden Acute Myeloid Leukemia Diagnostics Market, By Gender |
6.5.1 Overview and Analysis |
6.5.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Male, 2021- 2031F |
6.5.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Female, 2021- 2031F |
6.6 Sweden Acute Myeloid Leukemia Diagnostics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Associated Labs, 2021- 2031F |
6.6.4 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Independent Diagnostic Laboratories, 2021- 2031F |
6.6.5 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Diagnostic Imaging Centres, 2021- 2031F |
6.6.6 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Cancer Research Institutes, 2021- 2031F |
6.6.7 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Sweden Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 Sweden Acute Myeloid Leukemia Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Sweden Acute Myeloid Leukemia Diagnostics Market Import-Export Trade Statistics |
7.1 Sweden Acute Myeloid Leukemia Diagnostics Market Export to Major Countries |
7.2 Sweden Acute Myeloid Leukemia Diagnostics Market Imports from Major Countries |
8 Sweden Acute Myeloid Leukemia Diagnostics Market Key Performance Indicators |
8.1 Average turnaround time for AML diagnostic tests |
8.2 Adoption rate of novel AML diagnostic technologies in Sweden |
8.3 Number of research studies and clinical trials focused on AML diagnostics in Sweden |
9 Sweden Acute Myeloid Leukemia Diagnostics Market - Opportunity Assessment |
9.1 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.4 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.6 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Sweden Acute Myeloid Leukemia Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Acute Myeloid Leukemia Diagnostics Market - Competitive Landscape |
10.1 Sweden Acute Myeloid Leukemia Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Acute Myeloid Leukemia Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here